Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Cited by (1,001)

Items 201–300 of 1,001

1. Applications of human organoids in the personalized treatment for digestive diseases
   Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma · 2022 · Signal Transduction and Targeted Therapy
2. 3D modeling in cancer studies
   Oula El Atat, Zahra Farzaneh, Mahsa Pourhamzeh, Fatima Taki, Ralph Joseph Abi‐Habib, Massoud Vosough, Mirvat El‐Sibai · 2021 · Human Cell
3. Druggable genome and precision medicine in cancer: current challenges
   Camille Dupont, Kristina Riegel, Malvika Pompaiah, Hartmut H. Juhl, Krishnaraj Rajalingam · 2021 · FEBS Journal
4. Enabling peristalsis of human colon tumor organoids on microfluidic chips
   Fang, Guocheng, Lu, Hongxu, Al-Nakashli, Russul, Chapman, Robert, Zhang, Yingqi, Ju, Lining Arnold, Lin, Gungun, Stenzel, Martina H, Jin, Dayong · 2022 · Biofabrication
5. Immune organoids: from tumor modeling to precision oncology
   Vinh A Dao, Kanako Yuki, Yuan‐Hung Lo, Michitaka Nakano, Calvin Jay Kuo · 2022 · Trends in cancer
6. Bone Organoids: Recent Advances and Future Challenges
   Ding Zhao, Qimanguli Saiding, Yihan Li, Yunkai Tang, Wenguo Cui · 2023 · Advanced Healthcare Materials
7. Human Pluripotent Stem Cell-Derived Endoderm for Modeling Development and Clinical Applications
   Loukia Yiangou, Alexander Ross, Kim Jee Goh, Ludovic Vallier · 2018 · Cell stem cell
8. An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids
   Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Mayu Ogawa, Kosuke Takagi, Kazuhito Goda, Naoyuki Okabe, Satoshi Muto et al. · 2019 · Cells
9. Mathematical Models of Organoid Cultures
   Sandra Montes-Olivas, Lucia Marucci, Martin Homer · 2019 · Frontiers in Genetics
10. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management
    Dimitriοs Schizas, Aikaterini T. Mastoraki, Eleni Routsi, Michail Papapanou, Dimitrios Tsapralis, Pantelis Vassiliu, Konstantinos P. Toutouzas, Evangelos S. Felekouras · 2020 · Hepatobiliary & pancreatic diseases international
11. Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool
    Nicole Prior, Christopher J. Hindley, Fabian Rost, Elena Melendez Esteban, Winnie W. Y. Lau, Berthold Göttgens, Steffen Rulands, Benjamin D. Simons, Meritxell Huch · 2019 · Development
12. Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
    Jing‐Hua Chen, Xiangpeng Chu, Jia‐Tao Zhang, Qiang Nie, Wen‐Fang Tang, Jian Su, Hong‐Hong Yan, Hongping Zheng, Ze‐Xin Chen, Xin Chen et al. · 2020 · Thoracic Cancer
13. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma
    Giulia Cristinziano, Manuela Porru, Dante Lamberti, Simonetta Buglioni, Francesca Rollo, Carla Azzurra Amoreo, Isabella Manni, Diana Giannarelli, Cristina Cristofoletti, Giandomenico Russo et al. · 2021 · Journal of Hepatology
14. Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
    Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, Jianyu He, Tiankun Liu, Liliang Ouyang, Wen Zhang, Xueli Zhang, Zhigang Zhang, Kaitai Zhang et al. · 2023 · Nature reviews. Immunology
15. Next-Generation Liver Medicine Using Organoid Models
    Akbari, Soheil, Arslan, Nur, Senturk, Serif, Erdal, Esra · 2019 · Frontiers in Cell and Developmental Biology
16. Organoid technology for tissue engineering
    Juan He, Xiaoyu Zhang, Xinyi Xia, Ming Han, Fei Li, Chunfeng Li, Yunguang Li, Dong Gao · 2020 · Journal of Molecular Cell Biology
17. Drug screening model meets cancer organoid technology
    Chen Liu, Tianyu Qin, Yuhan Huang, Yuan Li, Gang Chen, Chaoyang Sun · 2020 · Translational Oncology
18. From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
    Gat Rauner, Piyush B. Gupta, Charlotte Kuperwasser · 2025 · Nature Methods
19. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer
    Dong Chen, Yawen Tan, Zhichao Li, Wujiao Li, Lei Yu, Wei Chen, Yuchen Liu, Lisa Liu, Liangfeng Guo, Weiren Huang et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
20. Organoid technology in cancer precision medicine
    Xinyi Xia, Fei Li, Juan He, Rebiguli Aji, Dong Gao · 2019 · Cancer Letters
21. Targeting stemness of cancer stem cells to fight colorectal cancers
    Lei Du, Qi Cheng, Hao Zheng, Jinming Liu, Lei Liu, Quan Chen · 2021 · Seminars in Cancer Biology
22. Microphysiological system with continuous analysis of albumin for hepatotoxicity modeling and drug screening
    Arun Asif, Sung Hyuk Park, Afaque Manzoor Soomro, Muhammad Asad Ullah Khalid, Abdul Rahim Chethikkattuveli Salih, Bohye Kang, Faheem Ahmed, Kyung Hwan Kim, Kyung Hyun Choi · 2021 · Journal of Industrial and Engineering Chemistry
23. A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma
    Duangporn Saengwimol, Duangnate Rojanaporn, Vijender Chaitankar, Pamorn Chittavanich, Rangsima Aroonroch, Tatpong Boontawon, Weerin Thammachote, Natini Jinawath, Suradej Hongeng, Rossukon Kaewkhaw · 2018 · Scientific Reports
24. Towards manufacturing of human organoids
    Aswathi Ashok, Deepak Choudhury, Yu Fang, Walter Hunziker · 2019 · Biotechnology Advances
25. RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state
    Belenguer, Germán, Mastrogiovanni, Gianmarco, Pacini, Clare, Hall, Zoe, Dowbaj, Anna M., Arnes-Benito, Robert, Sljukic, Aleksandra, Prior, Nicole, Kakava, Sofia, Bradshaw, Charles R. et al. · 2022 · Nature Communications
26. Human branching cholangiocyte organoids recapitulate functional bile duct formation
    Floris J.M. Roos, Gilles S. van Tienderen, Haoyu Wu, Ignacio Bordeu, Dina Vinke, Laura Muñoz Albarinos, Kathryn Monfils, Sabrah Niesten, Ron Smits, Jorke Willemse et al. · 2022 · Cell stem cell
27. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment
    Zhang, Rui, Ma, Min, Lin, Xia-Hui, Liu, Hua-Hua, Chen, Jie, Chen, Jun, Gao, Dong-Mei, Cui, Jie-Feng, Ren, Zheng-Gang, Chen, Rong-Xin · 2018 · BMC Cancer
28. Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
    Keisaku Sato, Wenjun Zhang, Samira Safarikia, Abdulkadir Isidan, Angela M. Chen, Ping Li, Heather Francis, Lindsey Leann Kennedy, Leonardo Baiocchi, Domenico Alvaro et al. · 2020 · Hepatology
29. Recent progress on the organoids: Techniques, advantages and applications
    Xiaofeng Liu, Zhiyuan Zhou, Yao Zhang, Hao Zhong, Xiulei Cai, Rongfa Guan · 2025 · Biomedicine & Pharmacotherapy
30. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
    Giulia Raimondi, Ana Mato-Berciano, Silvia Pascual-Sabater, Maria Rovira-Rigau, Míriam Cuatrecasas, Constantino Fondevila, Santiago Sánchez-Cabús, Harry Begthel, Sylvia F. Boj, Hans C. Clevers et al. · 2020 · EBioMedicine
31. Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
    Bethany R. Bareham, Nikitas Georgakopoulos, Alba Matas‐Céspedes, Michelle Curran, Kourosh Saeb‐Parsy · 2021 · Cancer Immunology Immunotherapy
32. Organoid Technology: Current Standing and Future Perspectives
    Laleh Shariati, Yasaman Esmaeili, Shaghayegh Haghjooy Javanmard, Elham Bidram, Abbas Amini · 2021 · Stem Cells
33. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
    Ergang Wang, Kun Xiang, Yun Zhang, Xiao‐Fan Wang · 2022 · Journal of the National Cancer Center
34. Novel patient-derived preclinical models of liver cancer
    Erin R. Bresnahan, Pierluigi Ramadori, Mathias F Heikenwälder, Lars Zender, Amaia Lujambio · 2020 · Journal of Hepatology
35. Patient‐derived cancer organoids for drug screening: Basic technology and clinical application
    Xiaoxue Ren, Weikang Chen, Qingxia Yang, Xiaoxing Li, Lixia Xu · 2022 · Journal of Gastroenterology and Hepatology
36. TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
    Yin Kau Lam, Jianqing J. Yu, Hao Huang, Xiaofan Ding, Alissa M. Wong, Howard H.W. Leung, Anthony W.H. Chan, Kelvin K. K. Ng, Mingjing Xu, Xin Wang et al. · 2022 · Hepatology
37. Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
    Nuzhat Ahmed, Elif Kadife, Ali Raza, Mary K. Short, Paul T. Jubinsky, George Kannourakis · 2020 · Cells
38. High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing
    Xiaojun Yan, Lyu Zhou, Zhaozhao Wu, Xun Wang, Xiuyuan Chen, Fan Yang, Yanan Guo, Min Wu, Yuyang Chen, Wenjing Li et al. · 2018 · Biomaterials
39. A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
    Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, Samantha Sharma, Tao Yu, Ishara Moulana, Sheng Liu, Jun Wan, Paul R. Territo, Mateusz Opyrchal et al. · 2023 · Advanced Science
40. Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
    S.Y. Jeong, Minyong Kang · 2023 · International Journal of Molecular Sciences
41. Present Application and Perspectives of Organoid Imaging Technology
    Fei, Keyi, Zhang, Jinze, Yuan, Jin, Xiao, Peng · 2022 · Bioengineering
42. Organoid models of glioblastoma: advances, applications and challenges.
    Chaocai Zhang, Ming-Zhu Jin, Jiannong Zhao, Juxiang Chen, Weilin Jin · 2020 · PubMed Central
43. In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
    Savneet Kaur, Srivatsan Kidambi, Martí Ortega‐Ribera, Lê Thị Thanh Thủy, Natalia Nieto, Victoria Carroll Cogger, Wei‐Fen Xie, Frank Tacke, Jordi Gracia‐Sancho · 2022 · Cellular and Molecular Gastroenterology and Hepatology
44. Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
    Jelena Krstic, Isabel Reinisch, Katharina Schindlmaier, Markus Galhuber, Zina Riahi, Natascha Berger, Nadja Kupper, Elisabeth Moyschewitz, Martina Auer, Helene Michenthaler et al. · 2022 · Science Advances
45. Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors
    Wenwen Wang, Tinggan Yuan, Lili Ma, Yanjing Zhu, Jinxia Bao, Xiaofang Zhao, Yan Zhao, Yali Zong, Yani Zhang, Shuai Yang et al. · 2022 · Advanced Science
46. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
    Linfeng Xian, Pei Zhao, Xi Chen, Zhimin Wei, Hongxiang Ji, Jun Zhao, Wenbin Liu, Zishuai Li, Donghong Liu, Xue Han et al. · 2022 · Cellular Oncology
47. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Fiona Helen Blackhall, Kristopher K. Frese, Kathryn Simpson, Elaine Kilgour, Gerard Brady, Caroline Dive · 2018 · The Lancet Oncology
48. Organoid Models for Cancer Research
    Hans C. Clevers, David A. Tuveson · 2019 · Annual Review of Cancer Biology
49. Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study
    Zhaoyan Liu, Xuying Tan, QiJiong Li, Gong‐Cheng Liao, Aiping Fang, Daoming Zhang, Peiyan Chen, Xiaoyan Wang, Yun Luo, Jing‐An Long et al. · 2018 · Nutrition & Metabolism
50. Vascularized Lung Cancer Model for Evaluating the Promoted Transport of Anticancer Drugs and Immune Cells in an Engineered Tumor Microenvironment
    Dasom Kim, Kyeong Seob Hwang, Eun U Seo, Su‐Yeong Seo, Byung Chul Lee, Nakwon Choi, Jonghoon H. Choi, Hong Nam Kim · 2022 · Advanced Healthcare Materials
51. Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
    Tara L. Hogenson, Hao Xie, William J. Phillips, Merih Deniz Toruner, Jing Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan Michael Carr et al. · 2022 · JCI Insight
52. Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
    Ryan C. Smith, Viviane S. Tabar · 2018 · Cell stem cell
53. Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
    Leticia Colyn, Marina Bárcena‐Varela, Gloria Álvarez‐Sola, Maria Ujue Latasa, Iker Uriarte, Eva Santamaría, José M. Herranz, Álvaro Santos‐Laso, María Arechederra, Mikel Ruiz de Gauna et al. · 2020 · Hepatology
54. Human liver organoids: From generation to applications
    Afonso, Marta B., Marques, Vanda, van Mil, Saskia W.C., Rodrigues, Cecilia M.P. · 2024 · Hepatology
55. Organoid models of the tumor microenvironment and their applications
    Tao Xia, Wen‐Lin Du, Xiaoyi Chen, You-Ni Zhang · 2021 · Journal of Cellular and Molecular Medicine
56. Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy
    Lichan Chen, Xiafei Wei, Dayong Gu, Yong Xu, Hongzhong Zhou · 2023 · Cancer Letters
57. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
    Stephanie Talamantes, Michela Lisjak, Eduardo Hideo Gilglioni, Camilo J. Llamoza-Torres, Bruno Ramos‐Molina, Esteban N. Gurzov · 2023 · JHEP Reports
58. Breaking the mold: 3D cell cultures reshaping the future of cancer research
    Sandra Zorat Cordeiro, Beatriz B P P Oliveira, Rúben Valente, Daniela Ferreira, André Luz, Pedro Viana Baptista, Alexandra Ramos Fernandes · 2024 · Frontiers in Cell and Developmental Biology
59. The frontier of live tissue imaging across space and time
    Qiang Huang, Aliesha Garrett, Shree Bose, Stephanie J. Blocker, Anne C. Rios, Hans C. Clevers, Xiling Shen · 2021 · Cell stem cell
60. Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
    Yawen Dong, Jeffrey Sum Lung Wong, Ryohichi Sugimura, Ka On Lam, Bryan K. Li, Gin Wai Kwok, Roland Ching-Yu Leung, Joanne Wing Yan Chiu, Tan To Cheung, Thomas C. C. Yau · 2021 · Cancers
61. Patient-Derived Organoids of Cholangiocarcinoma
    Christopher Maier, Lei Zhu, Lahiri Kanth Nanduri, Daniel Kühn, Susan Kochall, May-Linn Thepkaysone, Doreen William, Konrad Grützmann, Barbara Klink, Johannes Betge et al. · 2021 · International Journal of Molecular Sciences
62. Hepatocyte organoids and cell transplantation: What the future holds
    Weng Chuan Peng, Lianne J. Kraaier, Thomas Alexander Kluiver · 2021 · Experimental & Molecular Medicine
63. Primary human organoids models: Current progress and key milestones
    Giuseppe Calà, Beatrice Sina, Paolo De Coppi, Giovanni Giuseppe Giobbe, M Gerli · 2023 · Frontiers in Bioengineering and Biotechnology
64. The role of organoids in cancer research
    Zhen Fang, Peijuan Li, Fengying Du, Liang Shang, Leping Li · 2023 · Experimental Hematology and Oncology
65. Tumor organoids: From inception to future in cancer research
    Liang Yang, Shuo Yang, Xinyu Li, Bowen Li, Yan Li, Xiaodong Zhang, Yingbo Ma, Xueqiang Peng, Hongyuan Jin, Qing Fan et al. · 2019 · Cancer Letters
66. Milestones in the pathogenesis and management of primary liver cancer
    Jean‐Charles Nault, Ann‐Lii Cheng, Bruno Sangro, Josep Maria Llovet · 2020 · Journal of Hepatology
67. A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing
    James A. Saltsman, William J. Hammond, Nicole J.C. Narayan, David Requena, Helmuth Gehart, Gadi Lalazar, Michael P. LaQuaglia, Hans C. Clevers, Sanford M. Simon · 2020 · Cancers
68. Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform
    Steven Donald Forsythe, Shyama Sasikumar, Omeed Moaven, Hemamylammal Sivakumar, Perry Shen, Edward Allen Levine, Shay Söker, Aleksander Skardal, Konstantinos Ioannis Votanopoulos · 2020 · Annals of Surgical Oncology
69. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening
    Flávia Castro, Catarina Leite Pereira, Maria Helena Macedo, Andreia Almeida, Maria José Silveira, Sofia Dias, Ana Patrícia Cardoso, María José Oliveira, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Advanced Drug Delivery Reviews
70. Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids
    Hanbing Song, Simon Bucher, Katherine Rosenberg, Margaret Tsui, Deviana Burhan, Daniel B. Hoffman, Soo‐Jin Cho, Arun Atreiya Rangaswami, Marcus R. Breese, Stanley G. Leung et al. · 2022 · Nature Communications
71. Organoids in high-throughput and high-content screenings
    Franziska L. Lampart, Dagmar Iber, Nikolaos Doumpas · 2023 · Frontiers in Chemical Engineering
72. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
    Lehang Lin, De‐Chen Lin · 2019 · Cancers
73. Extracellular Matrix Mechanical Properties and Regulation of the Intestinal Stem Cells: When Mechanics Control Fate
    Lauriane Onfroy-Roy, Dimitri Hamel, Julie Foncy, Laurent Malaquin, Audrey Ferrand · 2020 · Cells
74. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
    Junya Shiota, Linda C. Samuelson, Nataliya Razumilava · 2021 · Hepatology
75. Exploring liver cancer biology through functional genetic screens
    Cun Wang, Ying Cao, Chen Guang Yang, René Bernards, Wenxin Qin · 2021 · Nature Reviews Gastroenterology & Hepatology
76. Advanced Biomaterials and Processing Methods for Liver Regeneration: State‐of‐the‐Art and Future Trends
    Alain da Silva Morais, Sílvia Vieira, Xinlian Zhao, Zhengwei Mao, Changyou Gao, Joaquim Miguel Oliveira, Rui Luís Reis · 2020 · Advanced Healthcare Materials
77. Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury
    Christopher R. Cox, Stephen Lynch, Christopher E. Goldring, Parveen Sharma · 2020 · Frontiers in Medical Technology
78. Cancer organoids: A platform in basic and translational research
    Xin Ma, Qin Lin Wang, Guozheng Li, Hui Li, Shouping Xu, Da Pang · 2023 · Genes & Diseases
79. Newly established patient-derived organoid model of intracranial meningioma
    Shintaro Yamazaki, Fumiharu Ohka, Masaki Hirano, Yukihiro Shiraki, Kazuya Motomura, Kuniaki Tanahashi, Takashi Tsujiuchi, Ayako Motomura, Kosuke Aoki, Keiko Shinjo et al. · 2021 · Neuro-Oncology
80. Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
    Xiaoxue Ren, Mingle Huang, Weixiang Weng, Yubin Xie, Yifan Wu, Shenghua Zhu, Ying Zhang, Dongming Li, Jiaming Lai, Shunli Shen et al. · 2023 · Cell Reports Medicine
81. Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy
    Xiaohua Xing, En Hu, Jiahe Ouyang, Xianyu Zhong, Fei Wang, Kaixin Liu, Linsheng Cai, Yang Zhou, Yingchao Wang, Geng Chen et al. · 2023 · Cell Reports Medicine
82. SPARC Stabilizes ApoE to Induce Cholesterol-Dependent Invasion and Sorafenib Resistance in Hepatocellular Carcinoma
    Shan Wan, Quan-Yao He, Yun Yang, Feng Liu, Xue Guang Zhang, Xin Guo, Hui Niu, Yi Wang, Yi-Xuan Liu, Wen-Long Ye et al. · 2024 · Cancer Research
83. Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
    Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, Layal Ashi, Rawan A Rahman AlHarmi, Noora Hassani · 2024 · Translational Oncology
84. Organoid of ovarian cancer: genomic analysis and drug screening
    Huidong Liu, Bairong Xia, Mingzhu Jin, Ge Lou · 2020 · Clinical & Translational Oncology
85. Generation of multi-cellular human liver organoids from pluripotent stem cells
    2020 · Methods in Cell Biology
86. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
    Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
87. Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management
    Han Wu, Ming-Da Wang, Lei Liang, Hao Xing, Chengwu Zhang, Feng Shen, Dong‐Sheng Huang, Tian Yang · 2021 · Small
88. The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
    Lauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang · 2019 · Animal Models and Experimental Medicine
89. Synthesizing biomaterials in living organisms
    Xiangyang Zhang, Junxia Wang, Ying Zhang, Zhimou Yang, Jie Gao, Zhen Gu · 2023 · Chemical Society Reviews
90. Engineered organoids for biomedical applications
    Natan Roberto de Barros, Canran Wang, Surjendu Maity, Arne Peirsman, Rohollah Nasiri, Anna Herland, Menekşe Ermis, Satoru Kawakita, Bruna Gregatti de Carvalho, Negar Hosseinzadeh Kouchehbaghi et al. · 2023 · Advanced Drug Delivery Reviews
91. Progress in human liver organoids
    Lulu Sun, Lijian Hui · 2020 · Journal of Molecular Cell Biology
92. Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models
    Katya A. D’Costa, Milena Kosic, Angus Lam, Azeen Moradipour, Yimu Zhao, Milica Radisic · 2020 · Annals of Biomedical Engineering
93. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
    Dan Shu, Meiying Shen, Kang Li, Xiaojian Han, Han Li, Zhaofu Tan, Yu Wang, Yang Peng, Zhenrong Tang, Chi Qu et al. · 2022 · Annals of Medicine
94. Personalized Cancer Models for Target Discovery and Precision Medicine
    Carla Grandori, Christopher J. Kemp · 2018 · Trends in cancer
95. Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
    Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, L. Frey, Yulong He, Andreas Geier, Enrico Narciso De Toni, Changhua Zhang et al. · 2023 · Liver Cancer
96. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer
    Xingfeng He, Yan J. Jiang, Long Zhang, Yaqi Li, Xiang Hu, Guoqiang Hua, Sanjun Cai, Shaobo Mo, Junjie Peng · 2023 · Frontiers in Bioengineering and Biotechnology
97. Pluripotent Stem Cell Platforms for Drug Discovery
    Kevin G. Chen, Barbara S. Mallon, Kyeyoon Park, Pamela Gehron Robey, Ronald D.G. McKay, Michael M. Gottesman, Wei Zheng · 2018 · Trends in Molecular Medicine
98. Liver Organoids: Formation Strategies and Biomedical Applications
    Xinglong Zhu, Bingqi Zhang, Yuting He, Ji Bao · 2021 · Tissue Engineering and Regenerative Medicine
99. A Patient-Derived Organoid-Based Radiosensitivity Model for the Prediction of Radiation Responses in Patients with Rectal Cancer
    Misun Park, Junhye Kwon, Joonseog Kong, Sun Mi Moon, Sangsik Cho, Ki Young Yang, Won Il Jang, Mi‐Sook Kim, Younjoo Kim, Ui Sup Shin · 2021 · Cancers
100. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues
     Hirosumi Tamura, Arisa Higa, Hirotaka Hoshi, Gen Hiyama, Nobuhiko Takahashi, Masae Ryufuku, Gaku Morisawa, Yuka Yanagisawa, Emi Ito, Junichi Imai et al. · 2018 · Oncology Reports